Has Merck Learned Anything from Vioxx and Vytorin?

alternet.org     22-May-2008            

It's getting tough to find any Merck drug that can hold up to scrutiny. Merck transposed its own clinical study results of 34 deaths in the Vioxx group and 12 in the placebo group to 29 deaths in the Vioxx group and 17 in the placebo group when it submitted data to the FDA, write Bruce Psaty, MD,... [read full story]                    


*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies